S&P Futures
2,444.75
-8.00 (-0.33%)Dow Futures
21,827.00
-59.00 (-0.27%)
| Previous Close | 0.094 |
| Open | 0.000 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 1,242,387 |
| Market Cap | 73.68M |
| Beta | -0.05 |
| PE Ratio (TTM) | -13.57 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Capital Cube•2 months agoElite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017
Categories: Yahoo FinanceGet free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Acura Pharmaceuticals, Inc., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc. and Albany Molecular Research, Inc. (MYL-US, ACUR-US, CBM-US, ACET-US, NKTR-US, PFE-US ... Read more (Read more...)
Capital Cube•5 months agoElite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q3, 2017 By the Numbers : March 15, 2017
Categories: Yahoo Finance Get free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc., Albany Molecular Research, Inc. and Akorn, Inc. (MYL-US, CBM-US, ACET-US, NKTR-US, PFE-US, AMRI-US and ... Read more (Read more...)
- TheStreet.com•last year
Trending Tickers: CZR, APO, MCUR, KS, ELTP
Caesars shares sink after a judge ruled that it would not be shielded from $11 billion in bondholder lawsuits.
